DEF 14A: Denali Therapeutics Sets Date for 2024 Annual Stockholders Meeting

Denali Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on May 31, 2024, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Denali Therapeutics Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 31, 2024, at 10:00 a.m. Pacific Time.
• Stockholders of record as of April 5, 2024, are entitled to vote.
• The meeting will address the election of three directors, ratification of Ernst & Young LLP as the independent accounting firm for the fiscal year ending December 31, 2024, and an advisory vote on executive compensation.
• The Board recommends voting for the election of the director nominees, for the ratification of Ernst & Young LLP, and for the approval of executive compensation.
• The company expects to mail the Notice of Internet Availability of Proxy Materials on or about April 18, 2024.
• As of the record date, there were 142,539,529 shares of common stock outstanding and entitled to vote.

Sentiment

Score: 7

Explanation: The document is a standard corporate communication, presenting factual information in a neutral tone. It aims to inform shareholders and facilitate participation in the annual meeting, reflecting a generally positive and proactive approach to corporate governance.

Positives

• The virtual format of the Annual Meeting allows the company to preserve stockholder access while saving time and money.
• The Board recommends voting FOR the election of directors, FOR the ratification of the accounting firm, and FOR the approval of executive compensation.

Management Comments

• Ryan J. Watts, Ph.D., President and Chief Executive Officer, expressed appreciation for stockholders' interest in Denali and urged them to vote.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to fulfill their corporate governance obligations.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence company decisions.
• The outcome of the votes will impact the composition of the board and executive compensation.

Next Steps

• Stockholders are encouraged to vote via the Internet, telephone, or mail.
• The company will file a report on Form 8-K to announce the final voting results within four business days after the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, Ernst & Young, Voting, Denali Therapeutics